Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Clinical trial NCT02467920 · COMPLETED
Trial details
- NCT number
- NCT02467920
- Sponsor
- Huazhong University of Science and Technology
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-12-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.